PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(13 sites)

United States

Massachusetts General Hospital, Boston, Massachusetts

NYU Langone Health, New York, New York

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Australia

Royal Melbourne Hospital, Parkville

Canada

McGill University Health Centre, Montreal, Quebec